Abstract
AHNAK2 is a protein discovered in 2004, with a strong association with oncogenesis in various epithelial cancers. It has a large 616 kDa tripartite structure and is thought to take part in the formation of large multi-protein complexes. High expression is found in clear cell renal carcinoma, pancreatic ductal adenocarcinoma, uveal melanoma, and lung adenocarcinoma, with a relation to poor prognosis. Little work has been done in exploring the function and relation AHNAK2 has with cancer, with early studies showing promising potential as a future biomarker and therapeutic target.
Cite
CITATION STYLE
Zardab, M., Stasinos, K., Grose, R. P., & Kocher, H. M. (2022). The Obscure Potential of AHNAK2. Cancers, 14(3), 528. https://doi.org/10.3390/cancers14030528
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.